Pacific Edge issues 1,335,471 options: what it means for Pacific Edge stock

Published on 10/02/2026 at 00:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

FY26 revenue fell 44.80 percent to NZD 13.60 million. For Pacific Edge stock this means a NZD 35.80 million FY26 loss, up 19.50 percent.

PEB, NZPEBE0002S1, Illustration mit AI erstellt.

Pacific Edge issued 1,335,471 employee options on September 14, 2026, according to TipRanks. The issue lifted total options to 46,997,014, making equity incentives a central part of the company story as it pursues a US reimbursement recovery.

What 1,335,471 options mean

The new options represent 0.11 percent of Pacific Edge's 1.24 billion shares on issue and carry exercise prices between NZD 0.281 and NZD 0.356 per share, according to TipRanks. The options vest in three equal annual tranches, so the immediate dilution is limited while the longer-term effect depends on employee retention and future exercises.

FY26 revenue fell 44.80 percent

Pacific Edge reported FY26 total revenue of NZD 13.60 million, down 44.80 percent, while the net loss widened 19.50 percent to NZD 35.80 million, middle.news reported on September 14, 2026. Operating cash outflow reached NZD 31.90 million, while year-end net cash stood at NZD 7.80 million. The comparison points to a business that needs higher test volumes and reimbursement progress to convert its diagnostic platform into sustainable growth.

The company raised NZD 36.10 million to support its next commercial phase. The proposed US Medicare coverage for Cxbladder Triage and Triage Plus carries draft pricing of USD 1,328 per test, with a final Local Coverage Determination expected by January 2027, according to middle.news.

NZX quote sits below yearly high

Pacific Edge was trading at NZD 0.26 on the NZX on October 2, 2026 at 11:24 a.m. NZDT. That price is 23.53 percent below the NZD 0.34 52-week high and NZD 0.12 above the NZD 0.14 low, while market capitalization stood at NZD 316.7 million on the same date.

Pacific Edge was also scheduled to join the S&P/NZX 50 in September, replacing KMD Brands, NZ Herald reported on September 9, 2026. For investors, the index inclusion adds a market-structure change to a story still defined by reimbursement execution, test volumes and cash use.